A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.

Sci Rep · 2017 · PMC5741731 · PMID 29273809

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

As single agent RG7787 caused a 40% reduction in median tumor volume versus the vehicle control group at day 30 when the study was terminated, however due to high variability within both groups this difference did not reach statistical significance (see boxplot in Fig. 6c ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.